Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

/p>

Total liabilities and equity137,942147,975SHANGPHARMA CORPORATIONUNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS(in thousands of U.S. dollars, except for ADS(1) data and per ADS data) 

 

Three months ended

Six months ended 

 

June 30,

June 30, 

 

2010

2011

% Change

2010

2011

% Change  

Net revenue

21,826

27,508

26.0%

41,554

52,282

25.8% 

Cost of revenue

(14,421)

(18,359)

27.3%

(27,209)

(35,134)

29.1% 

Gross profit

7,405

9,149

23.6%

14,345

17,148

19.5% Operating expenses  Selling and marketing

(558)

(588)

5.4%

(1,074)

(1,061)

-1.2% General and administrative

(3,606)

(5,732)

59.0%

(6,904)

(10,781)

56.2% 

Total operating expenses

(4,164)

(6,320)

51.8%

(7,978)

(11,842)

48.4% 

Profit from operations

3,241

2,829

-12.7%

6,367

5,306

-16.7%  

Other income, net:

1,417

1,350

-4.7%

1,449

2,403

65.8% 

Income from operations before income taxes

4,658

4,179

-10.3%

7,816

7,709

-1.4%  

Income taxes

(521)

(827)

58.7%

(948)

(1,347)

42.1% 

Net income

4,137

3,352

-19.0%

6,868

6,362

-7.4%  

Allocation to preferred shareholders

(1,042)

-

-100.0%

(1,729)

-

-100.0% 

Net income attributable to ordinary shareholders

3,095

'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
8. Neurologix Announces Second Quarter 2011 Financial Results
9. Bion Announces New U.S. Patent for Phosphorus Removal
10. ViaCyte Announces Executive Management Changes
11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... July 29, 2015 , ... Rainbow Scientific, Inc. (RSI), a ... availability of BI’s line of human mesenchymal stem cell (hMSC) differentiation media, ... offer a complete system for multipotency evaluation of hMSCs and reliable induction of ...
(Date:7/28/2015)... ... ... 530 sample changer for vials can be used with Anton Paar density meters, viscometers ... mPas (internal air) up to 36,000 (external air) – and can process up to 71 ... is its removable magazine, which is easily lifted off its hub and carried by hand ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2
... today the,submission of the response to the FDA ... Single Dose Containers). In an,Approvable Letter received on ... respect to chemistry, manufacturing, and controls (CMC)., ... response as a Class 2,resubmission, under which the ...
... 5 Telik, Inc.,(Nasdaq: TELK ) reported a ... for,the third quarter ended September 30, 2008, compared with ... for the comparable period in 2007. The,$8.0 million net ... municipal notes investments with an auction reset feature, or,auction ...
... and DUBLIN, November 5 Shire plc,(LSE: SHP, ... it has successfully settled all pending litigation in,connection ... Shire will pay the same price of $37 ... the time of the July 2005 merger, plus,interest., ...
Cached Biology Technology:SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R) 2Telik Announces Financial Results for 2008 Third Quarter 2Telik Announces Financial Results for 2008 Third Quarter 3Telik Announces Financial Results for 2008 Third Quarter 4Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation 2Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation 3
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... invades rice crops around the world, killing plants and cutting production ... a study by an international team of researchers has shed light ... plant tissue. The finding is a step toward learning how to ... feed 60 million people annually. The team, led ...
... University of Maryland-led team of policy experts and scientists ... change could affect civil conflicts. The team will develop ... and climate. They will use these to project future ... of Defense is funding the research through a new ...
... get rid of excess energy through the production of hydrogen. Biologists ... the absence of oxygen. For this, they need the messenger molecule ... red blood cells of humans. With colleagues at the UC Los ... Haemoglobin an old protein in a new look ...
Cached Biology News:Scientists discover new details about rice blast, a deadly plant fungus 2DoD-funded research: Can climate change heat up conflict? 2When green algae run out of air 2
Request Info...
Request Info...
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
Fast, sensitive quantitation of Mouse IgM concentration....
Biology Products: